The U-S Department of Health and Human Services points to new data that shows the Eli Lilly COVID therapies–as well as one developed by another drugmaker–are unlikely to work against the Omicron variant.
Lilly’s Bamlanivimab and Etesevimab, had emergency use authorization for treating mild to moderate cases in anyone as old as 12–expanded this month to children under 12. But the agency is waiting for “updated” data from the Centers for Disease Control and Prevention. That could bring a reversal.
Two other companies got their drugs back in distribution after being paused last month.
1 comment
So the geniuses in the Nazi federal health system take away a drug or treatment that will work against Delta Covid and original Covid. Why is that? What a foolish move! The Darth Fraudci worshipers always do the exact opposite thing that what should b done. More treatment options are needed not less.
You all need to read Robert F. Kennedy Jr’s new book “The Real Anthony Fauci.” That mug Fraudci should be in JAIL for his evil and self centered moves over Covid. Where are the Untouchables and Elliot Ness when we need them?